Loading…
Zenith Drugs (ZENITHDRUG)₹39.60+2.33%Pharmaceuticals
At the end of the Mar 2026 quarter, Zenith Drugs' shareholders were: promoters 70.02%, public 29.98%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 1,436 shareholders.
As of · Company filings (shareholding pattern)
| Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Promoters | 70.02% | 70.02% | 70.02% | 70.02% | 70.02% |
| FIIs | 5.75% | 0.42% | 0.06% | 0.00% | 0.00% |
| DIIs | 1.94% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 22.29% | 29.56% | 29.92% | 29.98% | 29.98% |
| Promoter shares pledged | — | — | — | — | 0.00% |
| Number of shareholders | 1,118 | 1,356 | 1,545 | 1,467 | 1,436 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Ajay Singh Dassundi | Promoter | 22.48% | — |
| Sandeep Bhardwaj | Promoter | 21.41% | — |
| Bhupesh Soni | Promoter | 20.19% | — |
| Jaywanti Soni | Promoter | 2.92% | — |
| Priyanka Bharadwaj | Promoter | 1.95% | — |
| Anjali Dassundi | Promoter | 0.80% | — |
| Saroj Soni | Promoter | 0.20% | — |
Promoters held 70.02% of Zenith Drugs at the end of the Mar 2026 quarter, the same as a year earlier.
In the Mar 2026 quarter, foreign institutional investors (FIIs) held 0.00% (unchanged at 0.00% a quarter earlier) and domestic institutions (DIIs) held 0.00% (unchanged at 0.00% a quarter earlier).
No. The Mar 2026 filing shows no pledged promoter shares.
Zenith Drugs had 1,436 shareholders at the end of the Mar 2026 quarter, against 1,118 a year earlier.